相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small-molecule drug repurposing to target DNA damage repair and response pathways
Jacqueline A. Brinkman et al.
SEMINARS IN CANCER BIOLOGY (2021)
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
Ievgenia Pastushenko et al.
NATURE (2021)
EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells
Yiping Wen et al.
THERANOSTICS (2021)
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Y. Garcia-Mayea et al.
SEMINARS IN CANCER BIOLOGY (2020)
Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state
Kosuke Mizukoshi et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Role of ATP-binding cassette transporters in cancer initiation and progression
Stefania Nobili et al.
SEMINARS IN CANCER BIOLOGY (2020)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
Lei Chen et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition
Igor Bado et al.
CANCER CELL (2020)
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
Federica Francescangeli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
Ross Kinstrie et al.
LEUKEMIA (2020)
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Francisco Triana-Martinez et al.
CELLS (2020)
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
Victor C. Kok
FRONTIERS IN ONCOLOGY (2020)
An Overview of Vasculogenic Mimicry in Breast Cancer
Marco A. Andonegui-Elguera et al.
FRONTIERS IN ONCOLOGY (2020)
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Yolla Haibe et al.
FRONTIERS IN ONCOLOGY (2020)
Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells
Souvick Roy et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Rowa Y. Alhabbab
FRONTIERS IN GENETICS (2020)
Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies
Vaishnavi Muralikrishnan et al.
CANCERS (2020)
Cancer Stem Cells and Its Role in Angiogenesis and Vasculogenic Mimicry in Gastrointestinal Cancers
Erik Lizarraga-Verdugo et al.
FRONTIERS IN ONCOLOGY (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-κ3 Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell
Majed Al Fayi et al.
ONCOLOGY RESEARCH (2020)
EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
Anthony Genna et al.
CANCERS (2020)
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
Maria Auxiliadora Olivares-Urbano et al.
CELLS (2020)
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Christopher Montemagno et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression
Sugandha Bhatia et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment
Weihai Ning et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Epithelial-Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance
Alex J. Gooding et al.
MOLECULAR CANCER RESEARCH (2020)
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
Stanislav Drapela et al.
MOLECULAR ONCOLOGY (2020)
KRAS: From undruggable to a druggable Cancer Target
Dipesh Uprety et al.
CANCER TREATMENT REVIEWS (2020)
Anthocyanins Isolated fromVitis coignetiae PulliatEnhances Cisplatin Sensitivity in MCF-7 Human Breast Cancer Cells through Inhibition of Akt and NF-κB Activation
Anjugam Paramanantham et al.
MOLECULES (2020)
miR-140-3p enhances cisplatin sensitivity and attenuates stem cell-like properties through repressing Wnt/β-catenin signaling in lung adenocarcinoma cells
Shuoming Wu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression
Entaz Bahar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies
Harinad Maganti et al.
LEUKEMIA RESEARCH (2020)
Management of ER positive metastatic breast cancer
Nicholas P. McAndrew et al.
SEMINARS IN ONCOLOGY (2020)
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
Yong-Hee Cho et al.
NATURE COMMUNICATIONS (2020)
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling
Wen-Xi Tan et al.
SCIENTIFIC REPORTS (2020)
Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker
Zhengyi Wang et al.
CANCER MEDICINE (2020)
CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
Angelique Sao-Mai Sy Do et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth
Rodolfo Molina-Pena et al.
CANCERS (2020)
The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy
Mei Guo et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
Ralf Hass et al.
CANCERS (2020)
The Tumor Microenvironment as a Driving Force of Breast Cancer Stem Cell Plasticity
Flavia Fico et al.
CANCERS (2020)
LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma
Shivani Baisiwala et al.
CANCERS (2020)
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy
Mirna Swayden et al.
CELLS (2020)
Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression
Dona Sinha et al.
BIOMOLECULES (2020)
Circulating tumor cell characterization of lung cancer brain metastases in the cerebrospinal fluid through single-cell transcriptome analysis
Haoyu Ruan et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer
Mei Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Kritika Saxena et al.
TRANSLATIONAL ONCOLOGY (2020)
Tumor Plasticity and Resistance to Immunotherapy
Lucas A. Horn et al.
TRENDS IN CANCER (2020)
The Time Has Come for Targeted Therapies for AML: Lights and Shadows
Alessandro Fiorentini et al.
ONCOLOGY AND THERAPY (2020)
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Co-expression of stem cell and epithelial mesenchymal transition markers in circulating tumor cells of bladder cancer patients
R. Zhang et al.
EUROPEAN UROLOGY SUPPLEMENTS (2019)
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
Lorenzo Castagnoli et al.
ONCOGENE (2019)
S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer
Shuang Liu et al.
CELL DEATH & DISEASE (2019)
A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells
Ilana Chefetz et al.
CELL REPORTS (2019)
Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
Narayanasamy Badrinath et al.
CANCERS (2019)
A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma
Nikki K. Lytle et al.
CELL (2019)
CELLULAR SENESCENCE: AGING, CANCER, AND INJURY
Arianna Calcinotto et al.
PHYSIOLOGICAL REVIEWS (2019)
A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
Ye-Bin Pang et al.
STEM CELLS INTERNATIONAL (2019)
Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer
Junli Xue et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
Junli Deng et al.
BMC CANCER (2019)
A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model
Nahla E. El-Ashmawy et al.
MOLECULAR IMMUNOLOGY (2019)
Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
Monica Marzagalli et al.
SEMINARS IN CANCER BIOLOGY (2019)
Cancer Stem Cells: From Historical Roots to a New Perspective
Jean-Pascal Capp
JOURNAL OF ONCOLOGY (2019)
Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis et al.
FRONTIERS IN ONCOLOGY (2019)
CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling
Hee-Joo Choi et al.
EMBO REPORTS (2019)
A patent review of RAF kinase inhibitors (2010-2018)
Ruo-Jun Man et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy
Masoud Najafi et al.
LIFE SCIENCES (2019)
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Monica Marzagalli et al.
SEMINARS IN CANCER BIOLOGY (2019)
Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
Xiaohong Ruan et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
Rana Jahanban-Esfahlan et al.
CANCERS (2019)
Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
Lizbeth Ayala-Dominguez et al.
FRONTIERS IN ONCOLOGY (2019)
Vasculogenic Mimicry: Become an Endothelial Cell But Not So Much
Monica Fernandez-Cortes et al.
FRONTIERS IN ONCOLOGY (2019)
Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells
Ti-Hui Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
Mario Giuliano et al.
LANCET ONCOLOGY (2019)
Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
Xianguang Bai et al.
ONCOTARGETS AND THERAPY (2019)
Dendritic cells loaded with CD44+ CT-26 colon cell lysate evoke potent antitumor immune responses
Changhao Fu et al.
ONCOLOGY LETTERS (2019)
Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration
Poulami Khan et al.
SCIENTIFIC REPORTS (2019)
CD200 Induces Epithelial-to-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma via β-Catenin-Mediated Nuclear Translocation
Seung-Phil Shin et al.
CANCERS (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Caner Saygin et al.
CELL STEM CELL (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
Luana Bavaro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Jorge E. Cortes et al.
LEUKEMIA (2019)
Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma
Lianghai Wang et al.
ONCOGENE (2019)
A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
Giacomo Domenici et al.
ONCOGENE (2019)
PD-L1 Expression on Lung Cancer Stem Cells in Metastatic Lymph Nodes Aspirates
Agata Raniszewska et al.
STEM CELL REVIEWS AND REPORTS (2019)
Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer
Megan M. Tu et al.
BLADDER CANCER (2019)
Controversies around epithelial-mesenchymal plasticity in cancer metastasis
Elizabeth D. Williams et al.
NATURE REVIEWS CANCER (2019)
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
Gwenola Manic et al.
GUT (2018)
Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer
Giuseppe Bronte et al.
BIOLOGICAL REVIEWS (2018)
Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR
Imran Shair Mohammad et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies
Yifeng Tao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Paracrine Wnt5a-beta-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
Fei Zhao et al.
IMMUNITY (2018)
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis
Julia A. Beaver et al.
LANCET ONCOLOGY (2018)
The PDGF/PDGFR pathway as a drug target
Natalia Papadopoulos et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells
Marzia Del Re et al.
STEM CELLS (2018)
ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
Xiang Zhang et al.
CELL DEATH & DISEASE (2018)
Identification of side population cells in human lung adenocarcinoma A549 cell line and elucidation of the underlying roles in lung cancer
Tong Xie et al.
ONCOLOGY LETTERS (2018)
Targeting melanoma stem cells with the Vitamin E derivative delta-tocotrienol
Monica Marzagalli et al.
SCIENTIFIC REPORTS (2018)
Melanoma Immunotherapy: Next-Generation Biomarkers
Sabrina A. Hogan et al.
FRONTIERS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence
Madhurima Das et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer
Lizet M. van der Waals et al.
PLOS ONE (2018)
Potential function of CTLA-4 in the tumourigenic capacity of melanoma stem cells
Bingyu Zhang et al.
ONCOLOGY LETTERS (2018)
EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
Keren Weidenfeld et al.
FRONTIERS IN ONCOLOGY (2018)
Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel
Yuki Izawa et al.
ACTA HISTOCHEMICA ET CYTOCHEMICA (2018)
SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
Xiaodong Yuan et al.
BRITISH JOURNAL OF CANCER (2018)
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Courtney L. Jones et al.
CANCER CELL (2018)
Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer
Yichao Wang et al.
MEDICINE (2018)
Cancer stem cell pipeline flounders
Ken Garber
NATURE REVIEWS DRUG DISCOVERY (2018)
Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
Sara R. Martins-Neves et al.
PHARMACOLOGICAL RESEARCH (2018)
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients
Elin Borgen et al.
BREAST CANCER RESEARCH (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors
Baocun Sun et al.
ONCOTARGET (2017)
TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence
Lucy Cassar et al.
PROTEIN & CELL (2017)
PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
Sheema Almozyan et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
Romana-Rea Begicevic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
Bahare Zarrin et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2017)
Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
Sara Duhachek-Muggy et al.
MOLECULAR CANCER (2017)
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
Su Yeon Lee et al.
MOLECULAR CANCER (2017)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications
Eunice Yuen-Ting Lau et al.
STEM CELLS INTERNATIONAL (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Orchestration of DNA Damage Checkpoint Dynamics across the Human Cell Cycle
Hui Xiao Chao et al.
CELL SYSTEMS (2017)
HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance
Babak Nami et al.
CANCERS (2017)
Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis
Zhaona Fan et al.
SCIENTIFIC REPORTS (2017)
Prognostic Factors and Survival Outcomes in Patients With Chronic Myeloid Leukemia in Blast Phase in the Tyrosine Kinase Inhibitor Era: Cohort Study of 477 Patients
Preetesh Jain et al.
CANCER (2017)
Increased PD-L1 expression in breast and colon cancer stem cells
Yanheng Wu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
The chronic myeloid leukemia stem cell: stemming the tide of persistence
Tessa L. Holyoake et al.
BLOOD (2017)
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma
Lan Yu et al.
DIAGNOSTIC PATHOLOGY (2017)
Homeostatic responses of colonic LGR5+ stem cells following acute in vivo exposure to a genotoxic carcinogen
Eunjoo Kim et al.
CARCINOGENESIS (2016)
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
Mauricio Rodriguez-Torres et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
Jose Alexandre Ferreira et al.
DRUG RESISTANCE UPDATES (2016)
Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer
Jun Liang et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2016)
Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis
Dhiraj Kumar et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
Ching-Feng Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail
Shuo Fang et al.
ONCOLOGY LETTERS (2016)
Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway
Wenchen Gong et al.
ONCOTARGET (2016)
Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis
Bo Cheng et al.
ONCOTARGET (2016)
cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer
Jiao Tang et al.
ONCOTARGET (2016)
Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer
Elizabeth Scheid et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines
Xiao-Yan Bai et al.
PLOS ONE (2016)
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Michael Goldstein et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
Margaret Soucheray et al.
CANCER RESEARCH (2015)
SMAD signaling and redox imbalance cooperate to induce prostate cancer cell dormancy
Anh Thu Bui et al.
CELL CYCLE (2015)
Stem cell-like gene expression signature identified in ionizing radiation-treated cancer cells
Jin-Han Bae et al.
GENE (2015)
ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis
Dong Wei et al.
HEART LUNG AND CIRCULATION (2015)
Wnt3a Promotes the Vasculogenic Mimicry Formation of Colon Cancer via Wnt/beta-Catenin Signaling
Lisha Qi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Side population cells and drug resistance in breast cancer
Meijian Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling
Carsten Riether et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
Tiyasha H. Ayub et al.
ONCOTARGET (2015)
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
Pramudita R. Prasetyanti et al.
ONCOTARGET (2015)
Trastuzumab resistance induces EMT to transform HER2+ PTEN- to a triple negative breast cancer that requires unique treatment options
Joseph P. Burnett et al.
SCIENTIFIC REPORTS (2015)
The Fibroblast Growth Factor signaling pathway
David M. Ornitz et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
A new paradigm for tumor immune escape: β-catenin-driven immune exclusion
Stefani Spranger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Mechanisms of resistance to EGFR tyrosine kinase inhibitors
Lihua Huang et al.
ACTA PHARMACEUTICA SINICA B (2015)
Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells
L. Kyjacova et al.
CELL DEATH AND DIFFERENTIATION (2015)
A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma
Yaping Shou et al.
CLINICAL CANCER RESEARCH (2015)
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways
Surendra Singh et al.
PLOS ONE (2015)
The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition
Michael Ruff et al.
PLOS ONE (2015)
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
Jinhuang Chen et al.
PLOS ONE (2015)
Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance
Jianjun Wang et al.
ONCOLOGY LETTERS (2015)
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis
J. Yan et al.
BRITISH JOURNAL OF CANCER (2014)
Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation
Cleo Yi-Fang Lee et al.
CANCER RESEARCH (2014)
Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy
Kristel Kemper et al.
CANCER RESEARCH (2014)
ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
Brian J. Wilson et al.
CANCER RESEARCH (2014)
Nras in melanoma: Targeting the undruggable target
Mario Mandala et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Aldehyde dehydrogenases in cancer: an opporunity for biomaker and drug development?
Klaus Pors et al.
DRUG DISCOVERY TODAY (2014)
Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer
Danfang Zhang et al.
MOLECULAR CANCER (2014)
The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
Francesca Pellicano et al.
STEM CELLS (2014)
Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Yingxi Xu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population
Rachel Eyre et al.
TUMOR BIOLOGY (2014)
Vascular channels formed by subpopulations of PECAM1+ melanoma cells
James M. Dunleavey et al.
NATURE COMMUNICATIONS (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
Maximilian Boesch et al.
ONCOTARGET (2014)
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
Katharina Feldinger et al.
ONCOTARGET (2014)
ABCG2-Meditated Multidrug Resistance and Tumor-Initiating Capacity of Side Population Cells from Colon Cancer
Zheng-Yuan Xie et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
Cheng-Po Huang et al.
CANCER LETTERS (2013)
HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
Suthinee Ithimakin et al.
CANCER RESEARCH (2013)
The involvement of Notch signaling in melanoma vasculogenic mimicry
Amalia Vartanian et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2013)
Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis
Yu-Cheng Ma et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Radiation-Induced Notch Signaling in Breast Cancer Stem Cells
Chann Lagadec et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
T. J. Liu et al.
ONCOGENE (2013)
The Role of MET Receptor Tyrosine Kinase in Non-Small Cell Lung Cancer and Clinical Development of Targeted Anti-MET Agents
Kyle W. Robinson et al.
ONCOLOGIST (2013)
ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis
Takafumi Kuroda et al.
PLOS ONE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
A new perspective of vasculogenic mimicry: EMT and cancer stem cells
Yun-Long Fan et al.
ONCOLOGY LETTERS (2013)
Lung cancer tumorigenicity and drug resistance are enhanced through ALDHhiCD44hi tumor initiating cells
Jing Liu et al.
ONCOTARGET (2013)
Cancer Stem Cells: Distinct Entities or Dynamically Regulated Phenotypes?
Yunqing Li et al.
CANCER RESEARCH (2012)
Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition
Zhiyong Liu et al.
CANCER SCIENCE (2012)
The developing cancer stem-cell model: clinical challenges and opportunities
Louis Vermeulen et al.
LANCET ONCOLOGY (2012)
Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
E. Traer et al.
LEUKEMIA (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ionizing Radiation Induces Stemness in Cancer Cells
Laura Ghisolfi et al.
PLOS ONE (2012)
Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links
Christina Scheel et al.
SEMINARS IN CANCER BIOLOGY (2012)
VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth
Natasha Y. Frank et al.
CANCER RESEARCH (2011)
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
Maria Soledad Sosa et al.
CLINICAL CANCER RESEARCH (2011)
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
Christian Hurtz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
Gabriel L. Fiszman et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2011)
In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
Veronique Neumeister et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
Soufiane El Hallani et al.
BRAIN (2010)
Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling
James P. Sullivan et al.
CANCER RESEARCH (2010)
Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma Phenotype
Katharine M. Hardy et al.
CANCER RESEARCH (2010)
High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
Christel van den Hoogen et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Expression and Functional Significance of Twist1 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry
Tao Sun et al.
HEPATOLOGY (2010)
The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts
Josephine C. McAllister et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2010)
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome
Ting Li et al.
LABORATORY INVESTIGATION (2010)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
Glioblastoma stem-like cells give rise to tumour endothelium
Rong Wang et al.
NATURE (2010)
Breast cancer chemoresistance: Emerging importance of cancer stem cells
Suebwong Chuthapisith et al.
SURGICAL ONCOLOGY-OXFORD (2010)
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
Heidi A. Lane et al.
CLINICAL CANCER RESEARCH (2009)
Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
Alessandra Magnifico et al.
CLINICAL CANCER RESEARCH (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
p38α and p38γ Mediate Oncogenic ras-induced Senescence through Differential Mechanisms
Jinny Kwong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation
Christine Dierks et al.
CANCER CELL (2008)
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
Seiji Yano et al.
CANCER RESEARCH (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells
Maria M. Ho et al.
CANCER RESEARCH (2007)
Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling
Susumu Kobayashi et al.
CANCER RESEARCH (2006)
The role of the ErbB family members in non-small cell lung cancers sensitive to epidermal growth factor receptor kinase inhibitors
Jeffrey A. Engelman et al.
CLINICAL CANCER RESEARCH (2006)
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C. C. Liu et al.
CANCER BIOLOGY & THERAPY (2006)
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia
DWJ van der Schaft et al.
CANCER RESEARCH (2005)
A distinct side population of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
